Germany Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery

115 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
115
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Germany Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery

  1. 1. Germany Diabetes Care Devices Market Outlook to 2018-Glucose Monitoring and Insulin DeliveryReport Details:Published:September 2012No. of Pages: 99Price: Single User License – US$2500Germany Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin DeliverySummaryGlobalData’s new report, “Germany Diabetes Care Devices Market Outlook to 2018- GlucoseMonitoring and Insulin Delivery” provides key market data on the Germany Diabetes Care Devicesmarket. The report provides value (USD million), volume (units) and average price (USD) data foreach segment and sub-segment within two market categories – Glucose Monitoring and InsulinDelivery. The report also provides company shares and distribution shares data for each of theaforementioned market categories. The report is supplemented with global corporate-level profilesof the key market participants with information on company financials and pipeline products,wherever available.This report is built using data and information sourced from proprietary databases, primary andsecondary research and in-house analysis by GlobalData’s team of industry experts.Scope- Market size and company share data for Diabetes Care Devices market categories – GlucoseMonitoring and Insulin Delivery.- Annualized market revenues (USD million), volume (units) and average price (USD) data foreach of the segments and sub-segments within two market categories. Data from 2004 to 2011,forecast forward for 7 years to 2018.- 2011 company shares and distribution shares data for each of the two market categories.- Global corporate-level profiles of key companies operating within the Germany Diabetes CareDevicesmarket.- Key players covered include F. Hoffmann-La Roche Ltd., Sanofi, Medtronic, Inc., Eli Lilly andCompany, LifeScan, Inc., Novo Nordisk A/S and others.
  2. 2. Reasons to buy- Develop business strategies by identifying the key market categories and segments poised forstrong growth.- Develop market-entry and market expansion strategies.- Design competition strategies by identifying who-stands-where in the Germany Diabetes CareDevices competitive landscape.- Develop capital investment strategies by identifying the key market segments expected toregister strong growth in the near future.- What are the key distribution channels and what’s the most preferred mode of productdistribution – Identify, understand and capitalize.Get your copy of this report @http://www.reportsnreports.com/reports/197487-germany-diabetes-care-devices-market-outlook-to-2018-glucose-monitoring-and-insulin-delivery.htmlMajor points covered in Table of Contents of this report include1 Table of Contents1 Table of Contents 21.1 List of Tables 61.2 List of Figures 72 Introduction 92.1 What is This Report About? 93 Diabetes Care Devices In Germany 103.1 Diabetes Care Devices, Market Segmentation 103.2 Diabetes Care Devices, Germany, Overall Revenue ($m), USD Constant, 2004-2018 113.3 Diabetes Care Devices Market, Germany, Revenue Mix ($m), 2011 123.4 Diabetes Care Devices Market, Germany, Category Contribution (%), 2011 133.5 Diabetes Care Devices, Germany, Company Share (2010-2011) 204 Glucose Monitoring In Germany 224.1 Glucose Monitoring, Market Segmentation 224.2 Glucose Monitoring Market, Germany, Revenue Mix ($m), 2011 234.3 Glucose Monitoring Market, Germany, Segment Contribution (%), 2011 244.4 Glucose Monitoring Overall Revenue, (2004-2018). 254.4.1 Blood Glucose Meters, Revenue (2004-2018) 294.5 Glucose Monitoring Overall Volume (2004-2018) 334.5.1 Blood Glucose Meters, Volume (2004-2018) 374.6 Glucose Monitoring Average Price (2004-2018) 414.7 Glucose Monitoring Distribution Share (2010-2011) 424.8 Glucose Monitoring, Germany, Company Share (2010-2011) 435 Insulin Delivery In Germany 455.1 Insulin Delivery Market, Germany, Revenue Mix ($m), 2011 465.2 Insulin Delivery Market, Germany, Segment Contribution (%), 2011 47
  3. 3. 5.3 Insulin Delivery Overall Revenue, (2004-2018) 485.3.1 Insulin Pens, Revenue (2004-2018) 525.3.2 Insulin Pumps, Revenue (2004-2018) 565.4 Insulin Delivery Overall Volume (2004-2018) 605.4.1 Insulin Pens, Volume (2004-2018) 645.4.2 Insulin Pumps, Volume (2004-2018) 685.5 Insulin Delivery Average Price (2004-2018) 715.6 Insulin Delivery Distribution Share (2010-2011) 725.7 Insulin Delivery, Germany, Company Share (2010-2011) 736 Overview of Key Companies in Germany Diabetes Care Devices Market 756.1 F. Hoffmann-La Roche Ltd. 756.1.1 Company Overview 756.1.2 Share in the Germany Diabetes Care Devices Market 756.2 Sanofi 766.2.1 Company Overview 766.2.2 Share in the Germany Diabetes Care Devices Market 766.3 Medtronic, Inc. 776.3.1 Company Overview 776.3.2 Share in the Germany Diabetes Care Devices Market 776.4 Eli Lilly and Company 786.4.1 Company Overview 786.4.2 Share in the Germany Diabetes Care Devices Market 786.5 LifeScan, Inc. 796.5.1 Company Overview 796.5.2 Share in the Germany Diabetes Care Devices Market 796.6 Novo Nordisk A/S 806.6.1 Company Overview 806.6.2 Share in the Germany Diabetes Care Devices Market 806.7 Bayer HealthCare AG 816.7.1 Company Overview 816.8 Abbott Laboratories 816.8.1 Company Overview 816.9 Becton, Dickinson and Company 826.9.1 Company Overview 826.10 Animas Corporation 826.10.1 Company Overview 826.11 Ypsomed Holding AG 836.11.1 Company Overview 836.12 ARKRAY, Inc. 836.12.1 Company Overview 836.13 B. Braun Melsungen AG 846.13.1 Company Overview 84
  4. 4. 6.14 Terumo Corporation 846.14.1 Company Overview 847 Diabetes Care Devices Market Pipeline Products 858 Financial Deals Landscape 898.1 Partnerships 898.1.1 Insulet Expands Distribution Agreement With Ypsomed Holding 899 Recent Developments 909.1 Strategy And Business Planning 909.1.1 Jun 26, 2012: Roche To Shut New Jersey Site, Eliminate 1,000 Jobs 909.2 Research And Development 919.2.1 Mar 27, 2012: Bayer HealthCare And Tsinghua University Extend Innovative Drug DiscoveryPartnership 919.2.2 Jan 09, 2012: Bayer HealthCare To Share Lab Space With Start-Up Companies 919.3 Product News 929.3.1 Sep 08, 2008: Novo Nordisk Launches A Next Generation Of FlexPen 9210 Appendix 9310.1 Definitions of Markets Covered in the Report 9410.1.1 Diabetes Care Devices 9410.2 Research Methodology 9610.3 Secondary Research 9610.4 Primary Research 9710.5 Models 9710.6 Forecasts 9810.7 Expert Panels 9810.8 GlobalData Consulting 9810.9 Currency Conversion 9810.10 Contact Us 9810.11 Disclaimer 991.1 List of TablesTable 1: Diabetes Care Devices, Germany, Overall Revenue ($m), USD Constant, 2004-2018 11Table 2: Diabetes Care Devices Market, Germany, Category Contribution (%), 2011 13Table 3: Diabetes Care Devices, Germany, Cross-Segment Analysis, 2004-2018 15Table 4: Diabetes Care Devices, Germany, Overall Revenue ($m), USD Constant, Historic, 2004-2011 17Table 5: Diabetes Care Devices, Germany, Overall Revenue ($m), USD Constant, Forecast,2011-2018 19Table 6: Diabetes Care Devices, Germany, Company Share by Revenue ($m), USD Constant,2010-2011 21Table 7: Glucose Monitoring Market, Germany, Segment Contribution (%), 2011 24Table 8: Glucose Monitoring, Germany, Revenue ($m) USD Constant, by Segment, Historic,2004-2011 26
  5. 5. Table 9: Glucose Monitoring, Germany, Revenue ($m) USD Constant, by Segment, Forecast,2011-2018 28Table 10: Blood Glucose Meters, Germany, Revenue ($m) USD Constant, by Sub-Segment,Historic, 2004-2011 30Table 11: Blood Glucose Meters, Germany, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 32Table 12: Glucose Monitoring, Germany, Volume (Units) by Segment, Historic, 2004-2011 34Table 13: Glucose Monitoring, Germany, Volume (Units) by Segment, Forecast, 2011-2018 36Table 14: Blood Glucose Meters, Germany, Volume (Units) by Sub-Segment, Historic, 2004-201138Table 15: Blood Glucose Meters, Germany, Volume (Units) by Sub-Segment, Forecast, 2011-2018 40Table 16: Glucose Monitoring, Germany, Average Price ($), Historic, 2004-2011 41Table 17: Glucose Monitoring, Germany, Average Price ($), Forecast, 2011-2018 41Table 18: Glucose Monitoring, Germany, Distribution Share by Revenue ($m), USD Constant,2010-2011 42Table 19: Glucose Monitoring, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011 44Table 20: Insulin Delivery Market, Germany, Segment Contribution (%), 2011 47Table 21: Insulin Delivery, Germany, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 49Table 22: Insulin Delivery, Germany, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 51Table 23: Insulin Pens, Germany, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 53Table 24: Insulin Pens, Germany, Revenue ($m) USD Constant, by Sub-Segment, Forecast,2011-2018 55Table 25: Insulin Pumps, Germany, Revenue ($m) USD Constant, by Sub-Segment, Historic,2004-2011 57Table 26: Insulin Pumps, Germany, Revenue ($m) USD Constant, by Sub-Segment, Forecast,2011-2018 59Table 27: Insulin Delivery, Germany, Volume (Units) by Segment, Historic, 2004-2011 61Table 28: Insulin Delivery, Germany, Volume (Units) by Segment, Forecast, 2011-2018 63Table 29: Insulin Pens, Germany, Volume (Units) by Sub-Segment, Historic, 2004-2011 65Table 30: Insulin Pens, Germany, Volume (Units) by Sub-Segment, Forecast, 2011-2018 67Table 31: Insulin Pumps, Germany, Volume (Units) by Sub-Segment, Historic, 2004-2011 68Table 32: Insulin Pumps, Germany, Volume (Units) by Sub-Segment, Forecast, 2011-2018 70Table 33: Insulin Delivery, Germany, Average Price ($), Historic, 2004-2011 71Table 34: Insulin Delivery, Germany, Average Price ($), Forecast, 2011-2018 71Table 35: Insulin Delivery, Germany, Distribution Share by Revenue ($m), USD Constant, 2010-2011 72Table 36: Insulin Delivery, Germany, Company Share by Revenue ($m), USD Constant, 2010-
  6. 6. 2011 74Table 37: Diabetes Care Devices Market Pipeline Products 85Table 38: Insulet Expands Distribution Agreement With Ypsomed Holding 891.2 List of FiguresFigure 1: Diabetes Care Devices, Market Segmentation 10Figure 2: Diabetes Care Devices, Germany, Overall Revenue ($m), USD Constant, 2004-2018 11Figure 3: Diabetes Care Devices Market, Germany, Revenue Mix ($m), 2011 12Figure 4: Diabetes Care Devices Market, Germany, Category Contribution (%), 2011 13Figure 5: Diabetes Care Devices, Germany, Cross-Segment Analysis, 2004-2018 14Figure 6: Diabetes Care Devices, Germany, Overall Revenue ($m), USD Constant, Historic, 2004-2011 16Figure 7: Diabetes Care Devices, Germany, Overall Revenue ($m), USD Constant, Forecast,2011-2018 18Figure 8: Diabetes Care Devices, Germany, Company Share (%)-2011 20Figure 9: Glucose Monitoring, Market Segmentation 22Figure 10: Glucose Monitoring Market, Germany, Revenue Mix ($m), 2011 23Figure 11: Glucose Monitoring Market, Germany, Segment Contribution (%), 2011 24Figure 12: Glucose Monitoring, Germany, Revenue ($m) USD Constant, by Segment, Historic,2004-2011 25Figure 13: Glucose Monitoring, Germany, Revenue ($m) USD Constant, by Segment, Forecast,2011-2018 27Figure 14: Blood Glucose Meters, Germany, Revenue ($m) USD Constant, by Sub-Segment,Historic, 2004-2011 29Figure 15: Blood Glucose Meters, Germany, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 31Figure 16: Glucose Monitoring, Germany, Volume (Units) by Segment, Historic, 2004-2011 33Figure 17: Glucose Monitoring, Germany, Volume (Units) by Segment, Forecast, 2011-2018 35Figure 18: Blood Glucose Meters, Germany, Volume (Units) by Sub-Segment, Historic, 2004-201137Figure 19: Blood Glucose Meters, Germany, Volume (Units) by Sub-Segment, Forecast, 2011-2018 39Figure 20: Glucose Monitoring, Germany, Company Share (%), 2011 43Figure 21: Insulin Delivery, Market Segmentation 45Figure 22: Insulin Delivery Market, Germany, Revenue Mix ($m), 2011 46Figure 23: Insulin Delivery Market, Germany, Segment Contribution (%), 2011 47Figure 24: Insulin Delivery, Germany, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 48Figure 25: Insulin Delivery, Germany, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 50Figure 26: Insulin Pens, Germany, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 52
  7. 7. Figure 27: Insulin Pens, Germany, Revenue ($m) USD Constant, by Sub-Segment, Forecast,2011-2018 54Figure 28: Insulin Pumps, Germany, Revenue ($m) USD Constant, by Sub-Segment, Historic,2004-2011 56Figure 29: Insulin Pumps, Germany, Revenue ($m) USD Constant, by Sub-Segment, Forecast,2011-2018 58Figure 30: Insulin Delivery, Germany, Volume (Units) by Segment, Historic, 2004-2011 60Figure 31: Insulin Delivery, Germany, Volume (Units) by Segment, Forecast, 2011-2018 62Figure 32: Insulin Pens, Germany, Volume (Units) by Sub-Segment, Historic, 2004-2011 64Figure 33: Insulin Pens, Germany, Volume (Units) by Sub-Segment, Forecast, 2011-2018 66Figure 34: Insulin Pumps, Germany, Volume (Units) by Sub-Segment, Historic, 2004-2011 68Figure 35: Insulin Pumps, Germany, Volume (Units) by Sub-Segment, Forecast, 2011-2018 69Figure 36: Insulin Delivery, Germany, Company Share (%), 2011 73Figure 37: F. Hoffmann-La Roche Ltd., Company Share (%),Germany Diabetes Care DevicesMarket, 2011 75Figure 38: Sanofi, Company Share (%),Germany Diabetes Care Devices Market, 2011 76Figure 39: Medtronic, Inc., Company Share (%),Germany Diabetes Care Devices Market, 2011 77Figure 40: Eli Lilly and Company, Company Share (%),Germany Diabetes Care Devices Market,2011 78Figure 41: LifeScan, Inc., Company Share (%),Germany Diabetes Care Devices Market, 2011 79Figure 42: Novo Nordisk A/S, Company Share (%),Germany Diabetes Care Devices Market, 201180Contact: sales@reportsandreports.com for more information.

×